Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹2,451 Cr
up ₹33.7 Cr vs Dec 2019
- Stocks held
- 18
- unchanged
- Top 10 weight
- 75.1%
- of the portfolio in its ten largest
- Cash & debt
- 0.6%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 7
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In January 2020 it disclosed 18 stocks worth ₹2,451 Cr, up ₹33.7 Cr from Dec 2019. Its largest positions were Sun Pharmaceutical Industries Limited (10.5%), Dr. Reddy's Laboratories Limited (9.5%), Divi's Laboratories Limited (8.8%); the ten largest together made up 75.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 77.7% of its equity. Cash and debt stood at 0.6%. Compared with Dec 2019 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
96%
Top-10 weight is higher than 96% of peers
Breadth
4%
Holds more stocks than 4% of peers
Cash
8%
Holds more cash than 8% of peers
Holdings in January 2020
Download CSVEvery line the fund disclosed, with the change against Dec 2019. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 10.46%
- Δ weight
- down 0.28 pts
- Value
- ₹256 Cr
- Δ value
- down ₹3.3 Cr
- Status
- Trimmed
- Weight
- 9.53%
- Δ weight
- up 1.80 pts
- Value
- ₹234 Cr
- Δ value
- up ₹46.7 Cr
- Status
- Added
- Weight
- 8.76%
- Δ weight
- down 0.78 pts
- Value
- ₹215 Cr
- Δ value
- down ₹16 Cr
- Status
- Trimmed
- Weight
- 8.75%
- Δ weight
- down 0.74 pts
- Value
- ₹215 Cr
- Δ value
- down ₹15 Cr
- Status
- Trimmed
- Weight
- 7.33%
- Δ weight
- up 0.06 pts
- Value
- ₹180 Cr
- Δ value
- up ₹4 Cr
- Status
- Added
- Weight
- 7.05%
- Δ weight
- down 0.43 pts
- Value
- ₹173 Cr
- Δ value
- down ₹8 Cr
- Status
- Trimmed
- Weight
- 6.36%
- Δ weight
- up 0.94 pts
- Value
- ₹156 Cr
- Δ value
- up ₹24.9 Cr
- Status
- Added
- Weight
- 5.83%
- Δ weight
- up 0.22 pts
- Value
- ₹143 Cr
- Δ value
- up ₹7.3 Cr
- Status
- Added
- Weight
- 5.64%
- Δ weight
- up 0.18 pts
- Value
- ₹138 Cr
- Δ value
- up ₹6.2 Cr
- Status
- Added
- Weight
- 5.37%
- Δ weight
- up 0.22 pts
- Value
- ₹132 Cr
- Δ value
- up ₹7.1 Cr
- Status
- Added
- Weight
- 5.13%
- Δ weight
- down 1.05 pts
- Value
- ₹126 Cr
- Δ value
- down ₹23.7 Cr
- Status
- Trimmed
- Weight
- 4.87%
- Δ weight
- down 0.35 pts
- Value
- ₹119 Cr
- Δ value
- down ₹6.8 Cr
- Status
- Trimmed
- Weight
- 4.21%
- Δ weight
- down 1.26 pts
- Value
- ₹103 Cr
- Δ value
- down ₹29.1 Cr
- Status
- Trimmed
- Weight
- 3.72%
- Δ weight
- up 0.65 pts
- Value
- ₹91.3 Cr
- Δ value
- up ₹17 Cr
- Status
- Added
- Weight
- 2.74%
- Δ weight
- up 0.08 pts
- Value
- ₹67.1 Cr
- Δ value
- up ₹2.8 Cr
- Status
- Added
- Weight
- 1.84%
- Δ weight
- up 0.45 pts
- Value
- ₹45.1 Cr
- Δ value
- up ₹11.5 Cr
- Status
- Added
- Weight
- 1.34%
- Δ weight
- up 0.11 pts
- Value
- ₹32.8 Cr
- Δ value
- up ₹3.2 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 0.57%
- Δ weight
- up 0.15 pts
- Value
- ₹14 Cr
- Δ value
- up ₹3.7 Cr
- Status
- Added
- Weight
- 0.50%
- Δ weight
- up 0.04 pts
- Value
- ₹12.1 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
What changed, Dec 2019 to Jan 2020
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Dr. Reddy's Laboratories Limitedup ₹46.7 Cr (+1.80% pts)
- Alkem Laboratories Limitedup ₹24.9 Cr (+0.94% pts)
- Narayana Hrudayalaya Limitedup ₹17 Cr (+0.65% pts)
- Indoco Remedies Limitedup ₹11.5 Cr (+0.45% pts)
- Aurobindo Pharma Limited ₹7.3 Cr (+0.22% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2019, the weight rose most in Pharmaceuticals (+0.5 pts), and fell most in Pharmaceuticals & Biotechnology (−0.5 pts).
- Pharmaceuticals1.4% → 1.9%+0.5 pts
- Pharmaceuticals & Biotechnology78.2% → 77.7%−0.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2019 | Dec 2019 | Jan 2020 |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.2% | 78.2% | 77.7% |
| Healthcare Services | 21.1% | 20.4% | 20.5% |
| Pharmaceuticals | 0.7% | 1.4% | 1.9% |
Allocation in Jan 2020change vs Dec 2019
- Pharmaceuticals & Biotechnology (12)77.7%▼ 0.5 pts
- Healthcare Services (5)20.5%▲ 0.1 pts
- Pharmaceuticals (1)1.9%▲ 0.5 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jan 2020
0.6%
▲ 0.1 pts vs Dec 2019
- Cash alone
- 0.6%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- −<0.1% – 0.6%
- lowest to highest · record 0.6% in Nov 2019
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.